Menu

Ovid Therapeutics Inc. OVID

Full chart Compare
Set alert

Price alert · OVID

All alert types
2.85 USD 0.00 (+0.00%)

At closeNov 9, 2026, 7:59 PM EST

2.80 -0.05 -1.75%

After hours · Nov 9, 7:59 PM ET

2.83 Day range 3.09
1.18 52-week range 3.11
YTD
+74.85%
1 year
+115.91%

Revenue & Expenses

Other Income → Expenses: $25.02MExpenses → Selling, General & Admin: $24.11MExpenses → Research & Development: $25.58MGross Profit → Expenses: $7.25MRevenue → Gross Profit: $7.25MNet Loss → Expenses: $17.41MOther Income$25.02MGross Profit$7.25MNet Loss$17.41MExpenses$49.69MSelling, General & Admin$24.11MResearch & Development$25.58MRevenue$7.25M

Latest period ending Dec 31, 2025 · select a line to chart its full history

OVID annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
7.25M566.00K392.00K1.50M208.38M
7.25M566.00K392.00K1.50M208.38M
-42.44M-61.88M-59.28M-55.55M124.21M
-17.41M-26.43M-52.34M-54.17M122.83M
-0.23-0.37-0.73-0.771.76
OVID annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
15.08M28.23M28.97M46.80M189.73M
150.93M92.17M144.03M155.27M194.54M
20.27M23.94M56.23M22.99M14.80M
13.42M14.76M46.00M16.54M0
130.66M68.23M87.80M132.27M179.75M
OVID annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-38.33M-55.96M-45.78M-55.23M118.61M
-49.85M54.59M-2.58M-87.88M-1.82M
75.21M622.00K30.54M180.66K904.08K
-13.15M-740.00K-17.83M-142.93M117.69M